179 related articles for article (PubMed ID: 34821374)
1. FGD5‑AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/β‑catenin signaling pathway via miR‑577.
Zhang WT; Zhang JJ; Shao Q; Wang YK; Jia JP; Qian B; Tian XW; Yan WJ
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34821374
[TBL] [Abstract][Full Text] [Related]
2. lncRNA FGD5 antisense RNA 1 upregulates RORA to suppress hypoxic injury of human cardiomyocyte cells by inhibiting oxidative stress and apoptosis via miR‑195.
Cai X; Zhang P; Wang S; Hong L; Yu S; Li B; Zeng H; Yang X; Shao L
Mol Med Rep; 2020 Dec; 22(6):4579-4588. PubMed ID: 33174051
[TBL] [Abstract][Full Text] [Related]
3. Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.
Zhang J; Zhang K; Hou Y
Mol Med Rep; 2020 Aug; 22(2):687-696. PubMed ID: 32468065
[TBL] [Abstract][Full Text] [Related]
4. lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axis.
Fang K; Xu ZJ; Jiang SX; Tang DS; Yan CS; Deng YY; Zhao FY
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880593
[TBL] [Abstract][Full Text] [Related]
5. lncRNA VIM‑AS1 promotes cell proliferation, metastasis and epithelial‑mesenchymal transition by activating the Wnt/β‑catenin pathway in gastric cancer.
Sun JG; Li XB; Yin RH; Li XF
Mol Med Rep; 2020 Dec; 22(6):4567-4578. PubMed ID: 33173977
[TBL] [Abstract][Full Text] [Related]
6. miR‑192‑5p upregulation mediates the suppression of curcumin in human NSCLC cell proliferation, migration and invasion by targeting c‑Myc and inactivating the Wnt/β‑catenin signaling pathway.
Pan Y; Sun Y; Liu Z; Zhang C
Mol Med Rep; 2020 Aug; 22(2):1594-1604. PubMed ID: 32626956
[TBL] [Abstract][Full Text] [Related]
7. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
Han L; Zan Y; Huang C; Zhang S
Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
[TBL] [Abstract][Full Text] [Related]
8. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA FGD5‑AS1/microRNA‑133a‑3p upregulates aquaporin 1 to decrease the inflammatory response in LPS‑induced sepsis.
Chu Y; Wang X; Yu N; Li Y; Kan J
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498707
[TBL] [Abstract][Full Text] [Related]
10. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
12. lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
Wang H; Zhang P
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760218
[TBL] [Abstract][Full Text] [Related]
13. SMARCC2 combined with c‑Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β‑catenin signaling pathway.
Li C; Fei C; Li J; Wu H; Chen L; Roshani R; Li H; Shi L; Song C; Gu J; Lu Y; Zhou Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080022
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
Xin S; Ye X
Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of microRNA‑183‑5p inhibits the proliferation and invasion of colorectal cancer cells by inactivating the reticulocalbin‑2/Wnt/β‑catenin signaling pathway.
Wang G; Zhou J; Lu F; Qiu L; Xu L; Yang X; Miao Y
Mol Med Rep; 2019 May; 19(5):4475-4483. PubMed ID: 30896885
[TBL] [Abstract][Full Text] [Related]
17. microRNA‑577 inhibits cell proliferation and invasion in non‑small cell lung cancer by directly targeting homeobox A1.
Men L; Nie D; Nie H
Mol Med Rep; 2019 Mar; 19(3):1875-1882. PubMed ID: 30628697
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of p16ink4a regulates the Wnt/β‑catenin signaling pathway in pancreatic cancer cells.
Zhang H; Li X; Meng W; Zhang L; Zhu X; Bai Z; Yan J; Zhou W
Mol Med Rep; 2018 Feb; 17(2):2614-2618. PubMed ID: 29207089
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells
Xing P; Wang Y; Zhang L; Ma C; Lu J
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846784
[TBL] [Abstract][Full Text] [Related]
20. lnc‑MICAL2‑1 sponges miR‑25 to regulate DKK3 expression and inhibits activation of the Wnt/β‑catenin signaling pathway in breast cancer.
Yao J; Li G; Liu M; Yang S; Su H; Ye C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
